OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Release Date
2019
(2)
2024
(1)
2020
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Not available
S-EPMC6620379
|
biostudies-literature
Cite
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Not available
S-EPMC7448154
|
biostudies-literature
Cite
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Not available
S-EPMC6619057
|
biostudies-literature
Cite
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Not available
S-EPMC11873788
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets